돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 656613생성일: 2026년 10월 25일

Imidazole → (S)-2-(tert-Butyldimethylsilyloxy)-g-butyrolactone

https://huagongshe.com/reaction/656613

반응식

참여 물질

역할이름HCID투입량
반응물ImidazoleHCID 795—
반응물tert-Butyldimethylsilyl chlorideHCID 28928—
반응물2-Hydroxy-gamma-butyrolactone, (2S)-HCID 357853—
용매Diethyl EtherHCID 3283—
용매DimethylformamideHCID 6228—
생성물(S)-2-(tert-Butyldimethylsilyloxy)-g-butyrolactoneHCID 10965951100%

반응 단계

To a solution of (S)-3-hydroxydihydrofuran-2(3H)-one (91a, 5 g, 49 mmol) in anhydrous DMF (40 mL) was added imidazole (6.7 g, 98 mmol) and TBDMS-chloride (8.1 g, 54 mmol) and the reaction is stirred for 3 h. The reaction was diluted with diethyl ether and washed with 1N HCl×3. The organic phase was dried over anhydrous sodium sulfate and the solvent was removed in vacuo to yield (S)-3-(tert-butyldimethylsilyloxy)dihydrofuran-2(3H)-one (91b) as a clear oil (10.6 g, 49 mmol). 1H NMR (400 MHz, CHLOROFORM-d) δ 0.15 (s, 3H), 0.18 (s, 3H), 0.86-0.99 (m, 9H), 2.23 (dq, J=12.63, 8.67 Hz, 1H), 2.46 (dddd, J=12.63, 7.58, 6.57, 3.28 Hz, 1H), 2.84-3.01 (m, 1H), 4.20 (td, J=9.16, 6.44 Hz, 1H), 4.33-4.47 (m, 2H).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08071766B2
출처 데이터셋uspto-grants-2011_12
ORD IDord-8ec2a9d89d7141b88ccf856caf6ba98a
출처 메모uspto-grants-2011_12